Novartis AG - Net Receivables

Novartis AG's Fiscal Year is From January To December - All Figures are in USD, Billions.

The item "Net-Receivables" stands at 8.98 Billion United States Dollars as of 09/30/2025.

As of the end of Novartis AG's third quarter, the item "Net Receivables" stands at 8.98 Billion USD. This represents a decrease of -2.09 percent compared to it's value at the end of it's second quarter .


Regarding the One-Year-Change of the series, the current value constitutes an increase of 10.23 percent compared to the value the year prior.
The 1 year change in percent is 10.23.
The 3 year change in percent is 3.50.
The 5 year change in percent is 8.25.
The 10 year change in percent is 5.76.

The Serie's long term average value is 9.47 Billion United States Dollars. It's latest available value, on 09/30/2025, is 5.11 percent lower, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 09/30/2023, to it's latest available value, on 09/30/2025, is +26.55%.
The Serie's change in percent from it's maximum value, on 12/31/2013, to it's latest available value, on 09/30/2025, is -28.83%.